Cargando…
Increased Bone Mass in Mice after Single Injection of Anti-receptor Activator of Nuclear Factor-κB Ligand-neutralizing Antibody: EVIDENCE FOR BONE ANABOLIC EFFECT OF PARATHYROID HORMONE IN MICE WITH FEW OSTEOCLASTS
Receptor activator of nuclear factor-κB ligand (RANKL) is a pivotal osteoclast differentiation factor. To investigate the effect of RANKL inhibition in normal mice, we prepared an anti-mouse RANKL-neutralizing monoclonal antibody (Mab, clone OYC1) and established a new mouse model with high bone mas...
Autores principales: | Furuya, Yuriko, Mori, Kaoru, Ninomiya, Tadashi, Tomimori, Yoshiya, Tanaka, Sakae, Takahashi, Naoyuki, Udagawa, Nobuyuki, Uchida, Kohji, Yasuda, Hisataka |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Biochemistry and Molecular Biology
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3196100/ https://www.ncbi.nlm.nih.gov/pubmed/21862583 http://dx.doi.org/10.1074/jbc.M111.246280 |
Ejemplares similares
-
Stimulation of bone formation in cortical bone of the mice treated with a novel bone anabolic peptide with osteoclastogenesis inhibitory activity
por: Furuya, Yuriko, et al.
Publicado: (2012) -
Stimulation of Bone Formation in Cortical Bone of Mice Treated with a Receptor Activator of Nuclear Factor-κB Ligand (RANKL)-binding Peptide That Possesses Osteoclastogenesis Inhibitory Activity
por: Furuya, Yuriko, et al.
Publicado: (2013) -
Treatment of OPG-deficient mice with WP9QY, a RANKL-binding peptide, recovers alveolar bone loss by suppressing osteoclastogenesis and enhancing osteoblastogenesis
por: Ozaki, Yuki, et al.
Publicado: (2017) -
Sclerostin expression in trabecular bone is downregulated by osteoclasts
por: Koide, Masanori, et al.
Publicado: (2020) -
Osteoclastic bone resorption directly activates osteoblast function
por: Udagawa, Nobuyuki
Publicado: (2012)